摘要
目的 :探讨联合使用沙美特罗替卡松和常规疗法治疗慢阻肺(慢性阻塞性肺疾病)的临床效果。方法 :对2013年6月至2015年2月期间我院收治的86例慢阻肺患者的临床资料进行回顾性研究。我们按照随机数表法将这86例患者分为试验组和参照组,每组各有43例患者。为这两组患者均使用常规疗法进行治疗,在此基础上,为参照组患者加用布地奈德进行治疗,为试验组患者加用沙美特罗替卡松进行治疗。治疗结束后,比较两组患者治疗的效果、FEV1(一秒钟用力呼气的容积)和FEV1/FVC(一秒钟用力呼气量与用力肺活量的比值)。结果 :治疗结束后,两组患者FEV1和FEV1/FVC均较治疗前有明显的提高,其中试验组患者FEV1和FEV1/FVC均明显高于参照组患者,二者相比差异具有显著性(P<0.05)。试验组患者进行治疗的总有效率明显高于参照组患者,二者相比差异具有显著性(P<0.05)。结论 :联合使用沙美特罗替卡松和常规疗法治疗慢阻肺的临床效果确切,可有效地改善患者的肺功能。
Objective to analyze patients with copd application salmeterol assigned the clinical effect of treatment. Methods randomly selected from our hospital from June 2013 to February 2015 admitted during the period of 86 patients with chronic obstructive pulmonary disease, compared two groups of pulmonary function before. Results： after treatment with different clinical treatment, two groups of patients with lung function index were improved significantly, but the observation group, P0.05, with statistical significance. Conclusion salmeterol copd patients assigned treatment, significantly improved in patients with pulmonary function, is worth further clinical application promotion.
